Last $58.54 USD
Change Today -0.42 / -0.71%
Volume 13.1M
MRK On Other Exchanges
New York
EN Paris
Sao Paulo
As of 8:04 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bruce N. Kuhlik

Former Executive Vice President and General Counsel, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Mr. Bruce N. Kuhlik served as an Executive Vice President of Merck & Co. Inc. from January 2008 to July 1, 2014. Mr. Kuhlik served as General Counsel of Merck & Co. Inc. from August 1, 2007 to July 1, 2014, where he was responsible for Merck's legal and public affairs functions. He served as Senior Vice president of Merck & Co. Inc. form August 1, 2007 to January 2008. Mr. Kuhlik joined Merck in 2005 and served as Vice President and Associate General Counsel, where he ...

Read Full Background

Corporate Headquarters*

One Merck Drive
Whitehouse Station, New Jersey 08889

United States

Phone: 908-423-1000
Fax: --

Board Members Memberships*

Former Executive Vice President and General Counsel


BA 1978
Harvard College
JD 1981
Harvard Law School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$804,281

Stock Options*

Restricted Stock Awards$1,049,879
All Other Compensation$86,477
Exercised Options249,998
Exercised Options Value$3,044,889
Exercisable Options251,288
Exercisable Options Value$2,076,820
Unexercisable Options305,051
Unexercisable Options Value$2,561,625
Total Value of Options$7,683,334
Total Number of Options806,337

Total Compensation*

Total Annual Cash Compensation$1,443,083
Total Short Term Compensation$804,281
Other Long Term Compensation$1,136,356
Total Calculated Compensation$3,619,238
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $58.54 USD -0.42


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at